CALEB KROLL: Open Payments
NPI 1205921780 · OWINGS MILLS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$883 in 40 payments from 12 companies in 2025. Trend: 2023 $534 · 2024 $421 · 2025 $883
Food & beverage: $883
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $231 |
| Boston Scientific Corporation | 7 | $197 |
| Medtronic, Inc. | 5 | $136 |
| BIOTRONIK NRO, Inc. | 4 | $80 |
| Globus Medical, Inc. | 2 | $55 |
| Abbott Laboratories | 2 | $45 |
| ABBVIE INC. | 2 | $36 |
| TerSera Therapeutics LLC | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $25 |
| SPR Therapeutics, Inc | 1 | $21 |
Products named: WaveWriter Alpha Prime 16, Belbuca, INCEPTIV, XTAMPZA, Prospera, Senza, PROCLAIM, QULIPTA.
Industry payments across MD — which companies pay providers there.
